Thursday broker round-up
Wizz Air Holdings
1,383.00p
17:00 06/11/24
Wizz Air: HSBC downgrades to 'reduce' and lowers target price from 4,500.0p to 4,100.0p; JP Morgan keeps at 'overweight' and marks up target from 5,350.0p to 5,800.0p.
Fresnillo
699.00p
17:15 06/11/24
FTSE 100
8,166.68
17:00 06/11/24
FTSE 250
20,446.70
17:04 06/11/24
FTSE 350
4,502.41
17:04 06/11/24
FTSE All-Share
4,460.03
17:14 06/11/24
General Industrials
7,634.22
17:04 06/11/24
General Retailers
4,618.98
17:04 06/11/24
Health Care Equipment & Services
10,335.71
17:04 06/11/24
Melrose Industries
500.60p
16:45 06/11/24
Mining
11,492.88
17:04 06/11/24
Mitchells & Butlers
251.00p
16:40 06/11/24
Pets at Home Group
298.80p
16:40 06/11/24
Travel & Leisure
8,402.82
17:04 06/11/24
UDG Healthcare Public Limited Company (CDI)
1,079.00p
16:34 13/08/21
Pennon: HSBC downgrades to 'reduce' with target price of 1,160.0.
UDG: Barclays downgrades to 'equalweight' with 1,080.0p target price.
Rio Tinto: JP Morgan stays at 'overweight' but lowers target from 8,250.0p to 7,770.0p.
Man Group: Barclays stays at 'equalweight' and hikes target price from 170.0p to 210.0p.
Victrex: Barclays keeps at 'equalweight' and raises target price from 1,870.0p to 2,150.0p.
Metro Bank: Barclays stays at 'underweight' with target price unchanged at 115.0p.
Pets at Home: Peel Hunt downgrades from 'buy' to 'add' with target price of 525.0p.
Fresnillo: BMO upgrades to 'outperform' with a target price of 1,100.0p.
Mitchells & Butlers: Peel Hunt upgrades from 'hold' to 'buy' with a target price of 335.0p.
Croda: Liberum reiterates 'buy' and lifts target price from 7,400.0p to 9,200.0p.
Barclays: JP Morgan keeps at 'buy' and raises target price from 230.0p to 240.0p; Deutsche Bank stays at 'buy' and raises target from 230.0p to 240.0p.
Melrose: Citi reinstates coverage with a 'buy' recommendation and sets target price of 185.0p.
Mirriad Advertising: Canaccord Genuity keeps at 'speculative buy' but cuts target price from 58.0p to 44.0p.
National Express Group: Berenberg keeps at 'buy' but lowers target price from 370.0p to 340.0p.
AstraZeneca: ShoreCap reiterates 'buy'
Lloyds Banking Group: ShoreCap reiterates 'buy'